Paper22706173
Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review.
Ishiyama H and 7 others. Am J Clin Oncol, 2014. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review. Papers, record 22706173. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22706173
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Radiation Injuries | Major topic |
| Radiotherapy, Adjuvant | Major topic |
| Transurethral Resection of Prostate | Major topic |
| Urethra | Major topic |
| Urination Disorders | Major topic |
| Brachytherapy | |
| Constriction, Pathologic | |
| Humans | |
| Laser Therapy | |
| Male | |
| Prostatic Hyperplasia | |
| Risk Factors | |
| Severity of Illness Index | |
| Time Factors | |
| Urogenital System |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42814133 | Determinants of late genitourinary toxicity after definitive radiotherapy with or without intraprostatic simultaneous integrated boost in patients with prior transurethral resection of the prostate. | Strahlenther Onkol | 2026 | https://conductscience.org/library/papers/42814133 | PubMed |
| 42203958 | Comparative analysis of genitourinary toxicity following bladder outlet obstruction procedures in patients before versus after radiotherapy for localized prostate cancer: a retrospective cohort study using the TriNetX database. | Prostate Cancer Prostatic Dis | 2026 | https://conductscience.org/library/papers/42203958 | PubMed |
| 42093677 | External beam focal boost radiotherapy to intraprostatic lesions in prostate cancer: a scoping review. | Phys Imaging Radiat Oncol | 2026 | https://conductscience.org/library/papers/42093677 | PubMed |
| 41831200 | Late urinary toxicity after prostate intensity-modulated radiation therapy for patients with history of invasive interventions for prostate or bladder. | Jpn J Radiol | 2026 | https://conductscience.org/library/papers/41831200 | PubMed |
| 41531161 | Genitourinary Toxicity, Function, and Quality of Life in Patients Undergoing Prostate Radiation Therapy-A Scoping Review. | Low Urin Tract Symptoms | 2026 | https://conductscience.org/library/papers/41531161 | PubMed |
| 41230159 | Management of prostatic necrosis and the devastated bladder outlet-a narrative review. | Transl Androl Urol | 2025 | https://conductscience.org/library/papers/41230159 | PubMed |
| 41186693 | Does transurethral resection of prostate increase toxicity risk after simultaneous integrated boost radiotherapy? A matched cohort study with long-term follow-up. | Strahlenther Onkol | 2026 | https://conductscience.org/library/papers/41186693 | PubMed |
| 40697722 | Orchiepididymitis as a rare complication of TURP performed four weeks after high-dose-rate brachytherapy for prostate cancer. | J Contemp Brachytherapy | 2025 | https://conductscience.org/library/papers/40697722 | PubMed |
| 39851963 | Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity. | Curr Oncol | 2025 | https://conductscience.org/library/papers/39851963 | PubMed |
| 39410023 | Effect of Prior Transurethral Prostate Resection (TURP) or Laser Enucleation (ThuLEP) on Radiotherapy-Induced Toxicity and Quality of Life in Prostate Cancer Patients Undergoing Definitive Radiotherapy. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39410023 | PubMed |
| 39230728 | Functional outcomes following external beam radiation therapy for patients with prior holmium laser enucleation of the prostate. | World J Urol | 2024 | https://conductscience.org/library/papers/39230728 | PubMed |
| 39200769 | Results of Adjustable Trans-Obturator Male System for Stress Urinary Incontinence after Transurethral Resection or Holmium Laser Enucleation of the Prostate: International Multicenter Study. | J Clin Med | 2024 | https://conductscience.org/library/papers/39200769 | PubMed |
| 38750347 | Management of the Devastated Bladder Outlet after Prostate CANCER Treatment. | Curr Urol Rep | 2024 | https://conductscience.org/library/papers/38750347 | PubMed |
| 38681137 | Extreme hypofractionated stereotactic radiotherapy for localized prostate Cancer: Efficacy and late urinary toxicity according to transurethral resection of the prostate history. | Clin Transl Radiat Oncol | 2024 | https://conductscience.org/library/papers/38681137 | PubMed |
| 38179576 | Stereotactic body radiation therapy for prostate cancer after surgical treatment of prostatic obstruction: Impact on urinary morbidity and mitigation strategies. | Clin Transl Radiat Oncol | 2024 | https://conductscience.org/library/papers/38179576 | PubMed |
| 35116437 | Urological complications after radiation therapy-nothing ventured, nothing gained: a Narrative Review. | Transl Cancer Res | 2021 | https://conductscience.org/library/papers/35116437 | PubMed |
| 35024634 | Primary Tumor Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy. | Eur Urol Open Sci | 2022 | https://conductscience.org/library/papers/35024634 | PubMed |
| 34774676 | SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial. | Int J Radiat Oncol Biol Phys | 2022 | https://conductscience.org/library/papers/34774676 | PubMed |
| 34768438 | Devastated Bladder Outlet in Pelvic Cancer Survivors: Issues on Surgical Reconstruction and Quality of Life. | J Clin Med | 2021 | https://conductscience.org/library/papers/34768438 | PubMed |
| 34164950 | High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome. | Cancer Rep (Hoboken) | 2022 | https://conductscience.org/library/papers/34164950 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22706173
GET https://conductscience.org/api/papers/v1/22706173/cited_by?page=2